Additional Proxy Soliciting Materials (definitive) (defa14a)
June 07 2021 - 8:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934 (Amendment No. )
Filed
by the Registrant [X]
Filed
by a Party other than the Registrant [ ]
Check
the appropriate box:
[
]
|
Preliminary
Proxy Statement
|
[
]
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
[
]
|
Definitive
Proxy Statement
|
[X]
|
Definitive
Additional Materials
|
[
]
|
Soliciting
Material under §240.14a-12
|
Cocrystal
Pharma, Inc.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
[X]
|
No
fee required.
|
|
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials.
|
|
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
Cocrystal
Pharma, Inc. (the “Company”) is distributing the following announcement via email transmission to the stockholders of the
Company as of April 20, 2021 in connection with the annual meeting of stockholders of the Company to be held at 2:00 p.m. EST on June
16, 2021.
Cocrystal
Pharma, Inc. Reminds Stockholders to vote ahead of the 2021 Annual Meeting
|
●
|
Vote
today, with instructions provided by your broker. Every stockholder vote is important. EVEN IF YOU SOLD YOUR SHARES.
|
|
●
|
For
assistance with voting your shares, please contact Cocrystal Pharma, Inc.’s proxy Okapi Partners at (877) 629-6356
|
Cocrystal
Pharma, Inc. encourages all stockholders to vote with the board recommendations on ALL proposals in advance of the June 16th,
2021 virtual stockholder meeting.
Stockholders
that owned shares as of the April 20th, 2021 record date are urged to vote, even if they no longer own shares. Every vote is important.
Cocrystal
Pharma, Inc’s board of directors recommends stockholders vote “FOR” the proposal to approve an amendment to the Certificate
of Incorporation of the Company.
The
Charter Amendment requires the affirmative vote of at least a majority of the outstanding common stock entitled to vote
We
understand your concern, however, the Board has no current plans to issue any additional shares of common stock following the effectiveness
of the Charter Amendment.
Voting
online or by telephone are the easiest ways to vote:
Vote
Online (Highly Recommended): Follow the instructions provided by your broker, bank or other nominee on the Voting Instruction Form
(“VIF”). This form was mailed to the address on record with your broker and also emailed if you elected electronic notification.
You will need your voting control number which is included on the VIF to vote online.
Vote
by Telephone: Follow the instructions provided by your broker, bank or other nominee on the VIF mailed (or emailed) to you. You will
need your voting control number which is included on the VIF to vote via automated telephone service.
For
assistance with voting your shares, please contact Cocrystal Pharma, Inc.’s proxy solicitor Okapi Partners at (877) 629-6356/
212) 297 0720 (international)/ info@okapipartners.com.
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Apr 2023 to Apr 2024